HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takamitsu Sasaki Selected Research

Acidophil Adenoma

1/2021The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takamitsu Sasaki Research Topics

Disease

51Neoplasms (Cancer)
08/2022 - 01/2004
20Neoplasm Metastasis (Metastasis)
08/2022 - 03/2005
13Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 03/2010
13Colonic Neoplasms (Colon Cancer)
08/2020 - 01/2004
9Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2011
8Carcinoma (Carcinomatosis)
01/2021 - 05/2004
6Carcinogenesis
08/2022 - 02/2006
5Inflammation (Inflammations)
01/2022 - 03/2005
5Squamous Cell Carcinoma of Head and Neck
09/2020 - 06/2018
4Infections
11/2021 - 06/2011
4Atrophy
12/2020 - 11/2018
4Esophageal Achalasia (Megaesophagus)
11/2016 - 01/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
08/2007 - 07/2005
3Lymphatic Metastasis
05/2021 - 12/2006
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2020 - 02/2006
3Gallbladder Neoplasms (Gallbladder Cancer)
06/2012 - 06/2004
2Polyps
11/2021 - 05/2020
2Adenoma (Adenomas)
07/2021 - 05/2020
2Chemical and Drug Induced Liver Injury
01/2021 - 01/2021
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2018
2Sarcopenia
12/2020 - 01/2019
2Cachexia
12/2020 - 01/2019
2Breast Neoplasms (Breast Cancer)
05/2020 - 09/2015
2Hypertrophy
12/2019 - 10/2018
2Disease Progression
11/2018 - 06/2018
2Pancreatic Fistula (Pancreatic Fistulas)
04/2018 - 06/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 09/2008
2Lung Neoplasms (Lung Cancer)
08/2015 - 01/2011
2Hypoxia (Hypoxemia)
01/2015 - 01/2012
2Leukemia
04/2010 - 03/2005
2Crohn Disease (Crohn's Disease)
01/2010 - 03/2009
2Drug-Related Side Effects and Adverse Reactions
10/2008 - 08/2004
2Necrosis
05/2008 - 02/2003
1Glioma (Gliomas)
01/2022

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2004
8ErbB Receptors (EGF Receptor)IBA
01/2013 - 07/2005
7HMGB1 Protein (HMG1)IBA
08/2022 - 01/2004
6Claudin-4IBA
11/2020 - 12/2018
5Fluorouracil (Carac)FDA LinkGeneric
05/2021 - 07/2017
5Pharmaceutical PreparationsIBA
01/2021 - 08/2004
5Fatty Acids (Saturated Fatty Acids)IBA
08/2020 - 07/2017
5EnzymesIBA
12/2019 - 01/2011
5Irinotecan (Camptosar)FDA LinkGeneric
05/2008 - 05/2004
5Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2008 - 11/2005
4Linoleic Acid (Linoleate)IBA
01/2022 - 04/2006
4Glucose (Dextrose)FDA LinkGeneric
05/2021 - 01/2015
4Messenger RNA (mRNA)IBA
11/2018 - 05/2004
4elaidic acidIBA
04/2018 - 01/2017
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2008 - 07/2005
4AEE 788 (AEE788)IBA
01/2008 - 07/2005
3Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2019
3CytokinesIBA
05/2021 - 03/2005
3Proton Pump InhibitorsIBA
05/2020 - 01/2016
3Trans Fatty AcidsIBA
04/2018 - 01/2017
3CarcinogensIBA
01/2018 - 01/2011
3Telomerase (Telomerase Reverse Transcriptase)IBA
08/2015 - 08/2013
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2015 - 02/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 12/2007
3Transforming Growth Factor alpha (TGF-alpha)IBA
07/2008 - 12/2007
3Imatinib Mesylate (Gleevec)FDA Link
01/2008 - 11/2005
3OligodeoxyribonucleotidesIBA
11/2005 - 05/2004
2pterostilbeneIBA
04/2022 - 12/2020
2Calcibiotic Root Canal SealerIBA
01/2022 - 03/2010
2Pregnane X ReceptorIBA
01/2021 - 12/2019
2Phenobarbital (Luminal)FDA Link
01/2021 - 09/2015
2Pregnenolone Carbonitrile (PCN)IBA
01/2021 - 10/2020
2lauric acid (dodecanoic acid)IBA
12/2020 - 10/2019
2Lactic Acid (Lactate)FDA LinkGeneric
09/2020 - 01/2014
2SugarsIBA
08/2020 - 10/2019
2Clostridium enterotoxinIBA
05/2020 - 01/2020
2Cadherins (E-Cadherin)IBA
05/2020 - 11/2005
2TamoxifenFDA LinkGeneric
05/2020 - 09/2015
2Cisplatin (Platino)FDA LinkGeneric
12/2019 - 09/2015
2Biomarkers (Surrogate Marker)IBA
01/2019 - 10/2014
2Growth Factor ReceptorsIBA
12/2018 - 02/2008
2Angiotensin IIIBA
11/2018 - 01/2014
2Cytochrome P-450 CYP3AIBA
01/2015 - 01/2012
2CollagenIBA
01/2015 - 06/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2012 - 01/2008
2cytochrome P-450 CYP4B1 (CYP4B1)IBA
01/2011 - 09/2008
2human ERBB2 proteinIBA
05/2008 - 12/2007
2Tyrosine Kinase InhibitorsIBA
05/2008 - 07/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2008 - 12/2007
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2008 - 01/2008
2Biological ProductsIBA
01/2008 - 05/2005
2GemcitabineFDA Link
11/2005 - 07/2005
2Indicators and Reagents (Reagents)IBA
11/2005 - 07/2005
1Sunitinib (Sutent)FDA Link
04/2022
1MicroRNAs (MicroRNA)IBA
12/2021
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
11/2021

Therapy/Procedure

13Therapeutics
08/2022 - 07/2005
4Myotomy
11/2016 - 01/2016
4Laparotomy
03/2009 - 01/2002
2Neoadjuvant Therapy
05/2021 - 12/2019
2Oral Administration
12/2020 - 07/2005
2Pancreaticoduodenectomy
04/2018 - 06/2015
2Gastrectomy
01/2016 - 01/2011
2Laparoscopic Cholecystectomy
11/2014 - 01/2010
1Transplantation
08/2022
1Molecular Targeted Therapy
04/2022